[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
Ragin, C.C.R., Modugno, F. and Gollin, S.M. (2007) The Epidemiology and Risk Factors of Head and Neck Cancer: A Focus on Human Papillomavirus. Journal of Dental Research, 86, 104-114.
https://doi.org/10.1177/154405910708600202
|
[3]
|
Svajdova, M., Dubinsky, P. and Kazda, T. (2021) Radical Ex-ternal Beam Re-Irradiation in the Treatment of Recurrent Head and Neck Cancer: Critical Review. Head & Neck, 43, 354-366. https://doi.org/10.1002/hed.26485
|
[4]
|
Toneatti, D.J., Graf, R.R., Burkhard, J.P., et al. (2021) Survival of Dental Implants and Occurrence of Osteoradionecrosis in Irradiated Head and Neck Cancer Patients: A Systematic Re-view and Meta-Analysis. Clinical Oral Investigations, 25, 5579-5593. https://doi.org/10.1007/s00784-021-04065-6
|
[5]
|
Basheeth, N. and Patil, N. (2019) Biomarkers in Head and Neck Cancer an Update. Indian Journal of Otolaryngology and Head & Neck Surgery, 71, 1002-1011. https://doi.org/10.1007/s12070-019-01683-1
|
[6]
|
Ding, Z., Wang, N., Ji, N., et al. (2022) Proteomics Technolo-gies for Cancer Liquid Biopsies. Molecular Cancer, 21, Article No. 53. https://doi.org/10.1186/s12943-022-01526-8
|
[7]
|
Aebersold, R. and Mann, M. (2003) Mass Spectrometry-Based Proteomics. Nature, 422, 198-207.
https://doi.org/10.1038/nature01511
|
[8]
|
Zubarev, R.A. and Makarov, A. (2013) Orbitrap Mass Spectrome-try.
|
[9]
|
Glish, G.L. and Vachet, R.W. (2003) The Basics of Mass Spectrometry in the Twenty-First Century. Nature Reviews Drug Discovery, 2, 140-150. https://doi.org/10.1038/nrd1011
|
[10]
|
Wu, J.Y., Yi, C., Chung, H.R., et al. (2010) Potential Biomarkers in Saliva for Oral Squamous Cell Carcinoma. Oral Oncology, 46, 226-231. https://doi.org/10.1016/j.oraloncology.2010.01.007
|
[11]
|
Frangogiannis, N.G. (2012) Biomarkers: Hopes and Challenges in the Path from Discovery to Clinical Practice. Translational Research, 159, 197-204. https://doi.org/10.1016/j.trsl.2012.01.023
|
[12]
|
Nikanjam, M., Kato, S. and Kurzrock, R. (2022) Liquid Biopsy: Current Technology and Clinical Applications. Journal of Hematology & Oncology, 15, Article No. 131. https://doi.org/10.1186/s13045-022-01351-y
|
[13]
|
Lianidou, E. and Pantel, K. (2019) Liquid Biopsies. Genes, Chromosomes and Cancer, 58, 219-232.
https://doi.org/10.1002/gcc.22695
|
[14]
|
Wang, J., Chang, S., Li, G., et al. (2017) Application of Liquid Biopsy in Precision Medicine: Opportunities and Challenges. Frontiers of Medicine, 11, 522-527. https://doi.org/10.1007/s11684-017-0526-7
|
[15]
|
Gourin, C.G., Xia, Z.S., Han, Y., et al. (2006) Serum Protein Profile Analysis in Patients with Head and Neck Squamous Cell Carcinoma. Archives of Otolaryngology-Head & Neck Surgery, 132, 390-397.
https://doi.org/10.1001/archotol.132.4.390
|
[16]
|
Gourin, C.G., Zhi, W. and Adam, B.L. (2009) Proteomic Identifi-cation of Serum Biomarkers for Head and Neck Cancer Surveillance. Laryngoscope, 119, 1291-1302. https://doi.org/10.1002/lary.20279
|
[17]
|
Zhang, X., Hou, H., Chen, H., et al. (2018) Serum Metabolomics of Lar-yngeal Cancer Based on Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry. Biomed-ical Chromatography, 32, e4181.
https://doi.org/10.1002/bmc.4181
|
[18]
|
Patel, A., Patel, S., Patel, P. and Tanavde, V. (2022) Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We from the Clinic? Frontiers in Oncology, 12, Article ID: 828434. https://doi.org/10.3389/fonc.2022.828434
|
[19]
|
Ribeiro, I.P., de Melo, J.B. and Carreira, I.M. (2019) Head and Neck Cancer: Searching for Genomic and Epigenetic Biomarkers in Body Fluids—The State of Art. Molecular Cytoge-netics, 12, Article No. 33.
https://doi.org/10.1186/s13039-019-0447-z
|
[20]
|
Sridharan, G., Ramani, P., Patankar, S. and Vijayaraghavan, R. (2019) Evaluation of Salivary Metabolomics in Oral Leukoplakia and Oral Squamous Cell Carcinoma. Journal of Oral Pathology & Medicine, 48, 299-306.
https://doi.org/10.1111/jop.12835
|
[21]
|
Song, X., Yang, X., Narayanan, R., Shankar, V., Ethiraj, S., Wang, X., Duan, N., Ni, Y.H., Hu, Q. and Zare, R.N. (2020) Oral Squamous Cell Carcinoma Diagnosed from Saliva Metabolic Profiling. Proceedings of the National Academy of Sciences of the United States of America, 117, 16167-16173. https://doi.org/10.1073/pnas.2001395117
|
[22]
|
Vago, R., Ravelli, A., Bettiga, A., Casati, S., Lavorgna, G., Benigni, F., Salonia, A., Montorsi, F., Orioli, M., Ciuffreda, P. and Ottria, R. (2020) Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage. Cancers (Basel), 12, Article No. 870. https://doi.org/10.3390/cancers12040870
|
[23]
|
Bax, C., Taverna, G., Eusebio, L., Sironi, S., Grizzi, F., Guazzoni, G. and Capelli, L. (2018) Innovative Diagnostic Methods for Early Prostate Cancer Detection through Urine Analysis: A Review. Cancers (Basel), 10, Article No. 123.
https://doi.org/10.3390/cancers10040123
|
[24]
|
Taware, R., Taunk, K., Pereira, J.A.M., et al. (2017) Investigation of Urinary Volatomic Alterations in Head and Neck Cancer: A Non-Invasive Approach towards Diagnosis and Prognosis. Metabolomics, 13, Article No. 111.
https://doi.org/10.1007/s11306-017-1251-6
|
[25]
|
Chen, J., Hou, H., Chen, H., et al. (2019) Urinary Metabolomics for Discovering Metabolic Biomarkers of Laryngeal Cancer Using UPLC-QTOF/MS. Journal of Pharmaceutical and Biomedical Analysis, 167, 83-89.
https://doi.org/10.1016/j.jpba.2019.01.035
|
[26]
|
Ibrahim, W., Carr, L., Cordell, R., et al. (2021) Breathomics for the Clinician: The Use of Volatile Organic Compounds in Respiratory Diseases. Thorax, 76, 514-521. https://doi.org/10.1136/thoraxjnl-2020-215667
|
[27]
|
Sisco, E. and Forbes, T.P. (2021) Forensic Applications of DART-MS: A Review of Recent Literature. Forensic Chemistry, 22, Article ID: 100294. https://doi.org/10.1016/j.forc.2020.100294
|
[28]
|
Qin, Y., Zheng, X., Gao, W., et al. (2021) Tumor Microenviron-ment and Immune-Related Therapies of Head and Neck Squamous Cell Carcinoma. Molecular Therapy-Oncolytics, 20, 342-351. https://doi.org/10.1016/j.omto.2021.01.011
|
[29]
|
Amalric, A., Bastide, A., Attina, A., et al. (2022) Quan-tifying RNA Modifications by Mass Spectrometry: A Novel Source of Biomarkers in Oncology. Critical Reviews in Clinical Laboratory Sciences, 59, 1-18.
https://doi.org/10.1080/10408363.2021.1958743
|
[30]
|
Gasparri, R., Sedda, G., Noberini, R., et al. (2020) Clinical Application of Mass Spectrometry-Based Proteomics in Lung Cancer Early Diagnosis. Proteomics-Clinical Applications, 14, Article ID: 1900138.
https://doi.org/10.1002/prca.201900138
|